This is a preview of subscription content, log in via an institution to check access.
Reference
Institute for Clinical and Economic Review. Institute for Clinical and Economic Review's Final Report on VMAT2 Inhibitors for Tardive Dyskinesia Calls for Manufacturer and Payer Action to Lower Prices and Assure Adequate Access. Internet Document : 21 Dec 2017. Available from: URL: https://icer-review.org/announcements/td-final-report/
Rights and permissions
About this article
Cite this article
ICER issues final report on VMAT2 inhibitors for tardive dyskinesia. PharmacoEcon Outcomes News 794, 2 (2018). https://doi.org/10.1007/s40274-018-4600-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-4600-4